MILLIONS of obese Spaniards could be going from flab to fab with the help of two new weight-loss medicines.
Liraglitude and Naitrexona-Bupropion are going to be available from 2016 and can lead to at least a 5% drop in weight.
The six-month treatments aim to help the three million Spaniards – 27% of the population – who are clinically obese.
